{"brief_title": "A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.", "brief_summary": "Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.", "condition": "Breast Neoplasms", "intervention_type": "Drug", "intervention_name": "SU011248", "criteria": "Inclusion Criteria: - Anthracycline and taxane-refractory or intolerant metastatic breast cancer - Female Exclusion Criteria: - Prior treatment with 3 or greater regimens of chemotherapy in the advanced/metastatic disease setting beyond those containing anthracyclines/taxanes.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00078000.xml"}